Buprenorphine And Naloxone Tablet
Product Images NDC 62175-458

5 FDA label images from Lannett Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 62175-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets Usp 1)

Buprenorphine Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets Usp 1)
Chemical structure diagram of Buprenorphine, showing its molecular structure with notable groups and bonds, including the presence of an HCl moiety.*
FDA Label Image

Naloxone Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets Usp 2)

Naloxone Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets Usp 2)
Chemical structure of Buprenorphine, showing its molecular composition including rings and functional groups, labeled with HCl and 2H2O indicating its hydrochloride dihydrate form.*
FDA Label Image

Image (Buprenorphine And Naloxone Sublingual Tablets Usp 3)

Image (Buprenorphine And Naloxone Sublingual Tablets Usp 3)
An instructional illustration showing a person placing a sublingual tablet under their tongue inside an open mouth. The image depicts the proper method of administering a sublingual tablet, highlighting the tablet positioned beneath the tongue, consistent with the dosage form of Buprenorphine and Naloxone sublingual tablets.*
FDA Label Image

Label (Buprenorphine And Naloxone Sublingual Tablets Usp 4)

Label (Buprenorphine And Naloxone Sublingual Tablets Usp 4)
Label for Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg strength. The label indicates the product is by Lannett Company, Inc. It shows a package size of 30 tablets with storage instructions and a mention to see the package insert for dosage information. The label includes an NDC barcode and the Rx only designation.*
FDA Label Image

Label (Buprenorphine And Naloxone Sublingual Tablets Usp 5)

Label (Buprenorphine And Naloxone Sublingual Tablets Usp 5)
Label for Buprenorphine and Naloxone Sublingual Tablets, USP 8 mg/2 mg, distributed by Lannett Company, Inc. The label indicates the product is for prescription use only (Rx only) and contains 30 tablets. It includes storage instructions and emergency care advice if the tablets are taken accidentally by children. A barcode and the website link for print medication guides are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.